Jump to content

Recommended Posts

Posted

I'm on an automatic email list to receive news about lc clinical trials. (centerwatch.com) This came this morning:

Trial Information

Summary: Picoplatin or Topotecan as Second-Line Therapy for Patients with Small Cell Lung Cancer

This research study is designed for patients who have small cell lung cancer (SCLC) that is no longer responding to treatment. Patients will be randomized to receive either picoplatin, a new platinum-based agent that is currently under investigation, or topotecan (Hycamtin ®), in order to measure the efficacy and safety of each treatment. (Patients will be randomized 2:1 in favor of picoplatin.)

Small cell lung cancer is the most aggressive and lethal form of lung cancer. Combination chemotherapy, including platinum therapy, is the standard first-line treatment for SCLC. Despite high response rates to first-line chemotherapy, long-term survival is rare, as patients relapse and develop resistance to available agents.

Platinum drugs work by binding to DNA and preventing cell division, eventually leading to cell death. Cell division can be very rapid in aggressive tumors. However, many patients demonstrate a resistance to platinum drugs. Results from preclinical studies indicate that picoplatin (previously called AMD473 or ZD0473) may be able to overcome or partially overcome the primary mechanisms of platinum resistance. More than 500 patients have received picoplatin in previous Phase I or Phase II clinical trials.

In this Phase II study, eligible patients will be given picoplatin or topotecan in 21-day cycles. Subjects may receive treatment cycles for up to 1 year as long as they continue to respond to therapy or demonstrate stable disease, and are able to tolerate therapy.

Inclusion Criteria:

1)Diagnosis of resistant or refractory small cell lung cancer.

2)Patients must have had only one prior chemotherapy regimen (prior topotecan is not allowed).

(Additional eligibility criteria apply)

If you go to this link, they have a form you can fill out for more info or to be considered for participation.

http://www.centerwatch.com/patient/stud ... 80465.html

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.